• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kinetics and mechanisms of degradation of the antileukemic agent 5-azacytidine in aqueous solutions.

作者信息

Notari R E, DeYoung J L

出版信息

J Pharm Sci. 1975 Jul;64(7):1148-57. doi: 10.1002/jps.2600640704.

DOI:10.1002/jps.2600640704
PMID:50433
Abstract

The hydrolytic degradation of 5-azacytidine was studied spectrophotometrically as a function of pH, temperature, and buffer concentration. Loss of drug followed apparent first-order kinetics in the pH region below 3. At pH less than 1,5-azacytosine and 5-azauracil were detected; at higher pH values, drug was lost to products which were essentially nonchromophoric if examined in acidic solutions. The apparent first-order rate constants associated with formation of 5-azacytosine and 5-azauracil from 5-azacytidine are reported. Above pH 2.6, first-order plots for drug degradation are biphasic. Apparent first-order rate constants and coefficients for the biexponential equation are given as a function of pH and buffer concentration. A reaction mechanism consistent with the data is discussed together with problems associated with defining the stability of the drug in aqueous solutions. At 50 degrees, the drug exhibited maximum stability at pH 6.5 in dilute phosphate buffer. Similar solutions were stored at 30 degrees to estimate their useful shelflife. Within 80 min, 6 times 10(-4) M solutions of 5-azacytidine decreased to 90% of original potency based on assumptions related to the proposed mechanisms.

摘要

相似文献

1
Kinetics and mechanisms of degradation of the antileukemic agent 5-azacytidine in aqueous solutions.
J Pharm Sci. 1975 Jul;64(7):1148-57. doi: 10.1002/jps.2600640704.
2
5-Azacytidine hydrolysis kinetics measured by high-pressure liquid chromatography and 13C-NMR spectroscopy.
J Pharm Sci. 1979 Jul;68(7):807-12. doi: 10.1002/jps.2600680705.
3
Degradation kinetics of metronidazole in solution.甲硝唑在溶液中的降解动力学
J Pharm Sci. 1993 Jan;82(1):95-8. doi: 10.1002/jps.2600820121.
4
A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.新型蛋白酶体抑制剂盐霉素A(NPI - 0052)的β-内酯水解的机理与动力学研究
J Pharm Sci. 2007 Aug;96(8):2037-47. doi: 10.1002/jps.20835.
5
Stability of aqueous solutions of mibolerone.
J Pharm Sci. 1976 Dec;65(12):1777-9. doi: 10.1002/jps.2600651221.
6
Cefuroxime hydrolysis kinetics and stability predictions in aqueous solution.头孢呋辛在水溶液中的水解动力学及稳定性预测
J Pharm Sci. 1994 Apr;83(4):577-81. doi: 10.1002/jps.2600830427.
7
Methocarbamol degradation in aqueous solution.水溶液中甲氯芬酯的降解
J Pharm Sci. 1994 Apr;83(4):499-501. doi: 10.1002/jps.2600830411.
8
Stability of ricobendazole in aqueous solutions.利考苯达唑在水溶液中的稳定性。
J Pharm Biomed Anal. 2009 Jul 12;49(5):1282-6. doi: 10.1016/j.jpba.2009.02.032. Epub 2009 Mar 13.
9
Degradation kinetics and mechanism of N6-[(dimethylamino)methylene]mitomycin C in aqueous solutions.
J Pharm Sci. 1986 Feb;75(2):208-10. doi: 10.1002/jps.2600750223.
10
The aqueous stability of bupropion.丁丙诺啡的水稳定性。
J Pharm Biomed Anal. 2010 Nov 2;53(3):376-81. doi: 10.1016/j.jpba.2010.04.024. Epub 2010 May 4.

引用本文的文献

1
The role of aberrant DNA methylation in cancer initiation and clinical impacts.异常DNA甲基化在癌症发生及临床影响中的作用。
Ther Adv Med Oncol. 2024 Jan 28;16:17588359231220511. doi: 10.1177/17588359231220511. eCollection 2024.
2
Melatonin: A Potential Regulator of DNA Methylation.褪黑素:一种潜在的DNA甲基化调节因子。
Antioxidants (Basel). 2023 May 25;12(6):1155. doi: 10.3390/antiox12061155.
3
DNA methyltransferase inhibitor exposure-response: Challenges and opportunities.DNA 甲基转移酶抑制剂暴露-反应:挑战与机遇。
Clin Transl Sci. 2023 Aug;16(8):1309-1322. doi: 10.1111/cts.13548. Epub 2023 Jun 21.
4
Calculated p Values for a Series of Aza- and Deaza-Modified Nucleobases.一系列氮杂和去氮杂碱基的计算 p 值。
J Phys Chem A. 2023 Apr 20;127(15):3526-3534. doi: 10.1021/acs.jpca.3c01358. Epub 2023 Apr 10.
5
Inhibitors of DNA Methylation.DNA甲基化抑制剂
Adv Exp Med Biol. 2022;1389:471-513. doi: 10.1007/978-3-031-11454-0_17.
6
Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior.靶向肿瘤可塑性和癌症干细胞行为的表观遗传修饰物。
Cells. 2022 Apr 21;11(9):1403. doi: 10.3390/cells11091403.
7
The Contrasting Delayed Effects of Transient Exposure of Colorectal Cancer Cells to Decitabine or Azacitidine.结直肠癌细胞短暂暴露于地西他滨或阿扎胞苷后的对比性延迟效应。
Cancers (Basel). 2022 Mar 16;14(6):1530. doi: 10.3390/cancers14061530.
8
Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations.一种延长药物制剂中阿扎胞苷使用稳定性的新储存方法的开发与验证
Pharmaceuticals (Basel). 2021 Sep 21;14(9):943. doi: 10.3390/ph14090943.
9
DNA methylation inhibitors: Retrospective and perspective view.DNA 甲基化抑制剂:回顾与展望。
Adv Cancer Res. 2021;152:205-223. doi: 10.1016/bs.acr.2021.03.007. Epub 2021 May 4.
10
Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections.将病毒基因组合成作为对抗RNA病毒感染的广谱方法。
Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620976786. doi: 10.1177/2040206620976786.